Advertisement Processing Peripheral Blood Mononuclear Cells (PBMC) for Clinical Trials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

Processing Peripheral Blood Mononuclear Cells (PBMC) for Clinical Trials

PBMC-based analytical tests are crucial to accelerate the development of new vaccines, drug discovery, diagnostic development, Precision Medicine Research (eg. CAR-T cell therapy, gene therapy, etc), and toxicology applications. To this end, the supply of high-quality PBMC is an essential first step in the process.

To read more, please download this free white paper.